Identification of Candidate Genes Related to Synovial Macrophages in Rheumatoid Arthritis by Bioinformatics Analysis

References

• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108. doi:10.1016/S0140-6736(10)60826-4
   PubMed Web of Science ®Google Scholar
• Safiri S, Kolahi AA, Hoy D, et al. Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the global burden of disease study 2017. Ann Rheum Dis. 2019;78(11):1463–1471. doi:10.1136/annrheumdis-2019-215920
   PubMed Web of Science ®Google Scholar
• Yang M, Feng X, Ding J, Chang F, Chen X. Nanotherapeutics relieve rheumatoid arthritis. J Control Release. 2017;252:108–124. doi:10.1016/j.jconrel.2017.02.032
   PubMed Web of Science ®Google Scholar
• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–196. doi:10.1016/j.immuni.2017.02.006
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):281–286. doi:10.2174/1568010054022024
   PubMedGoogle Scholar
• Xi ZD, Ge HL. Role of macrophages and their products in the pathogenesis of rheumatoid arthritis. Chin J Nat. 2009;31:262–267. in Chinese. doi:10.3969/j.issn.0253-9608.2009.05.004
   Google Scholar
• Siouti E, Andreakos E. The many facets of macrophages in rheumatoid arthritis. Biochem Pharmacol. 2019;165:152–169. PMID: 30910693. doi:10.1016/j.bcp.2019.03.029
   PubMed Web of Science ®Google Scholar
• Yeo L, Adlard N, Biehl M, et al. Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis. Ann Rheum Dis. 2016;75(4):763–771. doi:10.1136/annrheumdis-2014-206921
   PubMed Web of Science ®Google Scholar
• Soler Palacios B, Estrada-Capetillo L, Izquierdo E, et al. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. J Pathol. 2015;235(3):515–526. doi:10.1002/path.4466
   PubMed Web of Science ®Google Scholar
• Okada Y, Eyre S, Suzuki A, Kochi Y, Yamamoto K. Genetics of rheumatoid arthritis: 2018 status. Ann Rheum Dis. 2019;78(4):446–453. doi:10.1136/annrheumdis-2018-213678
   PubMed Web of Science ®Google Scholar
• Tang CH. Research of pathogenesis and novel therapeutics in arthritis. Int J Mol Sci. 2019;20(7):1646. doi:10.3390/ijms20071646
   PubMed Web of Science ®Google Scholar
• Petryszak R, Burdett T, Fiorelli B, et al. Expression atlas update–a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments. Nucleic Acids Res. 2014;42(7):D926–932. doi:10.1093/nar/gkt1270
   PubMed Web of Science ®Google Scholar
• Chen Y, Qiu F, Yu B, et al. Metformin, an AMPK activator, inhibits activation of FLSs but promotes HAPLN1 secretion. Mol Ther Methods Clin Dev. 2020;17:1202–1214. doi:10.1016/j.omtm.2020.05.008
   PubMed Web of Science ®Google Scholar
• Cheng Q, Chen X, Wu H, Du Y. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis. J Transl Med. 2021;19(1):18. doi:10.1186/s12967-020-02689-y
   PubMed Web of Science ®Google Scholar
• Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis. 1994;53(1):39–44. doi:10.1136/ard.53.1.39
   PubMed Web of Science ®Google Scholar
• Kinne RW, Bräuer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res. 2000;2(3):189–202. doi:10.1186/ar86
   PubMedGoogle Scholar
• Rana AK, Li Y, Dang Q, Yang F. Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis. Int Immunopharmacol. 2018;65:348–359. doi:10.1016/j.intimp.2018.10.016
   PubMed Web of Science ®Google Scholar
• Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C. Akt signaling pathway in macrophage activation and M1/M2 polarization. J Immunol. 2017;198(3):1006–1014. doi:10.4049/jimmunol.1601515
   PubMed Web of Science ®Google Scholar
• Li J, Hsu HC, Mountz JD. Managing macrophages in rheumatoid arthritis by reform or removal. Curr Rheumatol Rep. 2012;14(5):445–454. doi:10.1007/s11926-012-0272-4
   PubMed Web of Science ®Google Scholar
• Hamerman JA, Pottle J, Ni M, He Y, Zhang ZY, Buckner JH. Negative regulation of TLR signaling in myeloid cells–implications for autoimmune diseases. Immunol Rev. 2016;269(1):212–227. doi:10.1111/imr.12381
   PubMed Web of Science ®Google Scholar
• Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem. 1999;68(1):965–1014. doi:10.1146/annurev.biochem.68.1.965
   PubMed Web of Science ®Google Scholar
• Qi W, Lin C, Fan K, et al. Hesperidin inhibits synovial cell inflammation and macrophage polarization through suppression of the PI3K/AKT pathway in complete Freund’s adjuvant-induced arthritis in mice. Chem Biol Interact. 2019;306:19–28. doi:10.1016/j.cbi.2019.04.002
   PubMed Web of Science ®Google Scholar
• Haruta K, Mori S, Tamura N, et al. Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats. Inflamm Res. 2012;61(6):551–562. doi:10.1007/s00011-012-0444-8
   PubMed Web of Science ®Google Scholar
• Daghestani HN, Pieper CF, Kraus VB. Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. Arthritis Rheumatol. 2015;67(4):956–965. doi:10.1002/art.39006
   PubMed Web of Science ®Google Scholar
• Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol. 2002;169(5):2643–2647. doi:10.4049/jimmunol.169.5.2643
   PubMed Web of Science ®Google Scholar
• Thorne RF, Wang Y, Zhang Y, et al. Evaluating nuclear translocation of surface receptors: recommendations arising from analysis of CD44. Histochem Cell Biol. 2020;153(2):77–87. doi:10.1007/s00418-019-01835-y
   PubMed Web of Science ®Google Scholar
• Heo R, Park JS, Jang HJ, et al. Hyaluronan nanoparticles bearing γ-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis. J Control Release. 2014;192:295–300. doi:10.1016/j.jconrel.2014.07.057
   PubMed Web of Science ®Google Scholar
• Naor D, Nedvetzki S, Walmsley M, et al. CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice. Ann NY Acad Sci. 2007;1110(1):233–247. doi:10.1196/annals.1423.025
   PubMed Web of Science ®Google Scholar
• Kontny E, Prochorec-Sobieszek M. Articular adipose tissue resident macrophages in rheumatoid arthritis patients: potential contribution to local abnormalities. Rheumatology. 2013;52(12):2158–2167. doi:10.1093/rheumatology/ket287
   PubMed Web of Science ®Google Scholar
• Grandaunet B, Syversen SW, Hoff M, et al. Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 2011;63(3):662–669. doi:10.1002/art.30163
   PubMed Web of Science ®Google Scholar
• Hosonuma M, Sakai N, Furuya H, et al. Inhibition of hepatocyte growth factor/c-Met signalling abrogates joint destruction by suppressing monocyte migration in rheumatoid arthritis. Rheumatology. 2021;60(1):408–419. doi:10.1093/rheumatology/keaa310
   PubMed Web of Science ®Google Scholar
• Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 2006;42(6):768–778. doi:10.1016/j.ejca.2006.01.006
   PubMed Web of Science ®Google Scholar
• Karatoprak C, Uyar S, Abanonu GB, Pehlevan SM, Okuroglu N, Demirtunc R. The levels of β-thromboglobulin in female rheumatoid arthritis patients as activation criteria. Rheumatol Int. 2013;33(5):1229–1232. doi:10.1007/s00296-012-2511-4
   PubMed Web of Science ®Google Scholar
• Szeremeta A, Jura-Półtorak A, Komosińska-Vassev K, Zoń-Giebel A, Kapołka D, Olczyk K. The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis. Scand J Rheumatol. 2017;46(3):171–179. doi:10.1080/03009742.2016.1203020
   PubMed Web of Science ®Google Scholar
• Andersson KME, Wasén C, Juzokaite L, et al. Inflammation in the hippocampus affects IGF1 receptor signaling and contributes to neurological sequelae in rheumatoid arthritis. Proc Natl Acad Sci USA. 2018;115(51):E12063–E12072. doi:10.1073/pnas.1810553115
   PubMed Web of Science ®Google Scholar
• Erlandsson MC, Lyngfelt L, Åberg ND, et al. Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis. BMC Med. 2019;17(1):141. doi:10.1186/s12916-019-1374-x
   PubMed Web of Science ®Google Scholar
• Desai RJ, Solomon DH, Schneeweiss S, Danaei G, Liao KP, Kim SC. Tumor necrosis factor-α inhibitor use and the risk of incident hypertension in patients with rheumatoid arthritis. Epidemiology. 2016;27(3):414–422. doi:10.1097/EDE.0000000000000446
   PubMed Web of Science ®Google Scholar
• Estrada CC, Maldonado A, Mallipattu SK. Therapeutic inhibition of VEGF signaling and associated nephrotoxicities. J Am Soc Nephrol. 2019;30(2):187–200. doi:10.1681/ASN.2018080853
   PubMed Web of Science ®Google Scholar
• Zetterberg E, Palmblad J, Wallensten R, Morfini M, Melchiorre D, Holmström M. Angiogenesis is increased in advanced haemophilic joint disease and characterised by normal pericyte coverage. Eur J Haematol. 2014;92(3):256–262. doi:10.1111/ejh.12227
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qiu H, Zhang H, Wang L, Zhuang C, Liu R. Vascular endothelial growth factor A (VEGFA) polymorphisms in Chinese patients with rheumatoid arthritis. Scand J Rheumatol. 2013;42(5):344–348. doi:10.3109/03009742.2013.787454
   PubMed Web of Science ®Google Scholar
• Lee HY, Lee M, Bae YS. Formyl peptide receptors in cellular differentiation and inflammatory diseases. J Cell Biochem. 2017;118(6):1300–1307. doi:10.1002/jcb.25877
   PubMed Web of Science ®Google Scholar
• Odobasic D, Jia Y, Kao W, et al. Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis. Int Immunopharmacol. 2018;61:140–149. doi:10.1016/j.intimp.2018.05.028
   PubMed Web of Science ®Google Scholar
• Park YJ, Park B, Lee M, et al. A novel antimicrobial peptide acting via formyl peptide receptor 2 shows therapeutic effects against rheumatoid arthritis. Sci Rep. 2018;8(1):14664. doi:10.1038/s41598-018-32963-5
   PubMed Web of Science ®Google Scholar